{
  "issues": [
    "Renal tool output is contradictory: eGFR (59 mL/min/1.73 m²) is flagged as a \"pass\" (low renal risk) while creatinine (1.7 mg/dL) is flagged as a \"fail\" and the overall summary is \"fail\" with a low confidence score (0.52).",
    "The tool’s summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" despite the presence of a creatinine value and timestamps for each check, indicating a processing error.",
    "Patient is hypotensive (MAP 59 mmHg, SBP 82 mmHg). Hypotension markedly increases the risk of contrast‑induced nephropathy (CIN) and may limit the safety of standard hydration protocols.",
    "Stage 3a CKD (eGFR 59) is not severe, but the combination of prerenal azotemia (BUN/Cr = 20), anemia, and recent ICU stay raises the risk beyond what the protocol’s renal safety note (which only warns when eGFR < 30) captures.",
    "Protocol selection does not specify contrast type (low‑osmolar vs. iso‑osmolar) or a reduced contrast volume tailored to the patient’s renal function and hemodynamics.",
    "Hydration recommendation is generic (1 mL/kg/hr) and does not account for the patient’s low MAP; aggressive fluids could worsen hypotension.",
    "No plan for post‑contrast renal function monitoring (e.g., repeat creatinine at 24 h and 48 h) is described.",
    "Alternative imaging options are limited to a V/Q scan; bedside transthoracic echocardiography for right‑ventricular strain could also aid PE assessment without contrast."
  ],
  "recommendations": [
    "Obtain a repeat serum creatinine (and BUN) with an exact timestamp immediately before contrast administration to verify current renal function.",
    "Document the patient’s height and weight to calculate BMI and weight‑based contrast dose accurately.",
    "If MAP remains <65 mmHg, consider a brief fluid bolus (e.g., 250 mL isotonic saline) followed by a reduced maintenance rate (0.5 mL/kg/hr) and simultaneous hemodynamic support (e.g., low‑dose norepinephrine) to stabilize blood pressure before contrast exposure.",
    "Use low‑osmolar or iso‑osmolar iodinated contrast and limit volume to the minimum required for pulmonary arterial opacification (e.g., 80–100 mL, weight‑based, instead of 100–150 mL).",
    "Apply a contrast‑dose‑to‑eGFR ratio calculation; aim for <1.0 g I/mL/min for added safety in this borderline renal function patient.",
    "Schedule post‑contrast renal labs at 24 hours and 48 hours, with clinical monitoring for any rise in creatinine (>0.3 mg/dL or 25% increase).",
    "If hemodynamic instability cannot be corrected or if repeat creatinine rises, abort contrast‑based imaging and proceed with a V/Q scan or bedside echocardiography for PE evaluation.",
    "Update the renal decision support tool with correct BMI and lab timestamps; consider re‑running the tool after the new labs are obtained to obtain a more reliable risk assessment.",
    "Add a note in the imaging order to alert the technologist and radiologist to the patient’s hypotension and CKD, prompting low‑dose contrast protocol and close post‑scan monitoring."
  ],
  "confidence": 0.77,
  "agent2_confidence": 0.78,
  "timestamp": "2025-08-26T10:04:31.995214Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-26T10:04:26.682269Z",
          "priority": "critical",
          "value": 59.0,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-26T10:04:26.682286Z",
          "priority": "critical",
          "value": 1.7,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-26T10:04:26.682291Z",
          "priority": "important",
          "value": 20.0,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-26T10:04:26.682303Z",
          "priority": "important",
          "value": 4.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-26T10:04:26.682336Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool output is contradictory: eGFR (59 mL/min/1.73 m²) is flagged as a \\\"pass\\\" (low renal risk) while creatinine (1.7 mg/dL) is flagged as a \\\"fail\\\" and the overall summary is \\\"fail\\\" with a low confidence score (0.52).\",\n    \"The tool’s summary lists \\\"Missing BMI or creatinine\\\" and \\\"No lab timestamps provided\\\" despite the presence of a creatinine value and timestamps for each check, indicating a processing error.\",\n    \"Patient is hypotensive (MAP 59 mmHg, SBP 82 mmHg). Hypotension markedly increases the risk of contrast‑induced nephropathy (CIN) and may limit the safety of standard hydration protocols.\",\n    \"Stage 3a CKD (eGFR 59) is not severe, but the combination of prerenal azotemia (BUN/Cr = 20), anemia, and recent ICU stay raises the risk beyond what the protocol’s renal safety note (which only warns when eGFR < 30) captures.\",\n    \"Protocol selection does not specify contrast type (low‑osmolar vs. iso‑osmolar) or a reduced contrast volume tailored to the patient’s renal function and hemodynamics.\",\n    \"Hydration recommendation is generic (1 mL/kg/hr) and does not account for the patient’s low MAP; aggressive fluids could worsen hypotension.\",\n    \"No plan for post‑contrast renal function monitoring (e.g., repeat creatinine at 24 h and 48 h) is described.\",\n    \"Alternative imaging options are limited to a V/Q scan; bedside transthoracic echocardiography for right‑ventricular strain could also aid PE assessment without contrast.\"\n  ],\n  \"recommendations\": [\n    \"Obtain a repeat serum creatinine (and BUN) with an exact timestamp immediately before contrast administration to verify current renal function.\",\n    \"Document the patient’s height and weight to calculate BMI and weight‑based contrast dose accurately.\",\n    \"If MAP remains <65 mmHg, consider a brief fluid bolus (e.g., 250 mL isotonic saline) followed by a reduced maintenance rate (0.5 mL/kg/hr) and simultaneous hemodynamic support (e.g., low‑dose norepinephrine) to stabilize blood pressure before contrast exposure.\",\n    \"Use low‑osmolar or iso‑osmolar iodinated contrast and limit volume to the minimum required for pulmonary arterial opacification (e.g., 80–100 mL, weight‑based, instead of 100–150 mL).\",\n    \"Apply a contrast‑dose‑to‑eGFR ratio calculation; aim for <1.0 g I/mL/min for added safety in this borderline renal function patient.\",\n    \"Schedule post‑contrast renal labs at 24 hours and 48 hours, with clinical monitoring for any rise in creatinine (>0.3 mg/dL or 25% increase).\",\n    \"If hemodynamic instability cannot be corrected or if repeat creatinine rises, abort contrast‑based imaging and proceed with a V/Q scan or bedside echocardiography for PE evaluation.\",\n    \"Update the renal decision support tool with correct BMI and lab timestamps; consider re‑running the tool after the new labs are obtained to obtain a more reliable risk assessment.\",\n    \"Add a note in the imaging order to alert the technologist and radiologist to the patient’s hypotension and CKD, prompting low‑dose contrast protocol and close post‑scan monitoring.\"\n  ],\n  \"confidence\": 0.87\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool output is contradictory: eGFR (59 mL/min/1.73 m²) is flagged as a \"pass\" (low renal risk) while creatinine (1.7 mg/dL) is flagged as a \"fail\" and the overall summary is \"fail\" with a low confidence score (0.52).",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "The tool’s summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" despite the presence of a creatinine value and timestamps for each check, indicating a processing error.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Patient is hypotensive (MAP 59 mmHg, SBP 82 mmHg). Hypotension markedly increases the risk of contrast‑induced nephropathy (CIN) and may limit the safety of standard hydration protocols.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '82'"
      },
      {
        "text": "Stage 3a CKD (eGFR 59) is not severe, but the combination of prerenal azotemia (BUN/Cr = 20), anemia, and recent ICU stay raises the risk beyond what the protocol’s renal safety note (which only warns when eGFR < 30) captures.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Protocol selection does not specify contrast type (low‑osmolar vs. iso‑osmolar) or a reduced contrast volume tailored to the patient’s renal function and hemodynamics.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Hydration recommendation is generic (1 mL/kg/hr) and does not account for the patient’s low MAP; aggressive fluids could worsen hypotension.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No plan for post‑contrast renal function monitoring (e.g., repeat creatinine at 24 h and 48 h) is described.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '48'"
      },
      {
        "text": "Alternative imaging options are limited to a V/Q scan; bedside transthoracic echocardiography for right‑ventricular strain could also aid PE assessment without contrast.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain a repeat serum creatinine (and BUN) with an exact timestamp immediately before contrast administration to verify current renal function.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document the patient’s height and weight to calculate BMI and weight‑based contrast dose accurately.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If MAP remains <65 mmHg, consider a brief fluid bolus (e.g., 250 mL isotonic saline) followed by a reduced maintenance rate (0.5 mL/kg/hr) and simultaneous hemodynamic support (e.g., low‑dose norepinephrine) to stabilize blood pressure before contrast exposure.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Use low‑osmolar or iso‑osmolar iodinated contrast and limit volume to the minimum required for pulmonary arterial opacification (e.g., 80–100 mL, weight‑based, instead of 100–150 mL).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Apply a contrast‑dose‑to‑eGFR ratio calculation; aim for <1.0 g I/mL/min for added safety in this borderline renal function patient.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Schedule post‑contrast renal labs at 24 hours and 48 hours, with clinical monitoring for any rise in creatinine (>0.3 mg/dL or 25% increase).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '48'"
      },
      {
        "text": "If hemodynamic instability cannot be corrected or if repeat creatinine rises, abort contrast‑based imaging and proceed with a V/Q scan or bedside echocardiography for PE evaluation.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Update the renal decision support tool with correct BMI and lab timestamps; consider re‑running the tool after the new labs are obtained to obtain a more reliable risk assessment.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Add a note in the imaging order to alert the technologist and radiologist to the patient’s hypotension and CKD, prompting low‑dose contrast protocol and close post‑scan monitoring.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "hemodynamic instability supported by MAP 59.0"
      }
    ],
    "counts": {
      "supported": 16,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 1,
      "contradicted": 0
    },
    "hallucination_score": 0.029,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 20028931.0,
        "hadm_id": 34567891.0,
        "stay_id": 44551234.0,
        "age": 72.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 4.2,
        "los_icu_days": 3.7,
        "creatinine_mg_dl": 1.7,
        "bun_mg_dl": 34.0,
        "glucose_mg_dl": 142.0,
        "hemoglobin_g_dl": 10.1,
        "hematocrit_pct": 30.5,
        "platelet_count": 210.0,
        "wbc_count": 12.3,
        "sodium_meq_l": 135.0,
        "potassium_mmol_l": 4.6,
        "chloride_meq_l": 100.0,
        "bicarbonate_meq_l": 21.0,
        "egfr_ckd_epi": 59.0,
        "ckd_stage": 3.0,
        "bun_creatinine_ratio": 20.0,
        "heart_rate_bpm": 95.0,
        "systolic_bp_mmhg": 82.0,
        "diastolic_bp_mmhg": 48.0,
        "map_mmhg": 59.0,
        "pulse_pressure_mmhg": 34.0,
        "temperature_f": 98.9,
        "spo2_pct": 94.0,
        "respiratory_rate": 22.0,
        "data_completeness_pct": 0.92
      },
      "raw_strings_sample": [
        "100.0",
        "bun/cr ratio suggests prerenal azotemia.",
        "21.0",
        "48",
        "white",
        "30.5",
        "3.7",
        "stage 3a (mild-to-moderate ckd)",
        "20.0",
        "right-sided chest pain with history of diabetes and hypertension"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool output is contradictory: eGFR (59 mL/min/1.73 m²) is flagged as a \"pass\" (low renal risk) while creatinine (1.7 mg/dL) is flagged as a \"fail\" and the overall summary is \"fail\" with a low confidence score (0.52).",
      "The tool’s summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" despite the presence of a creatinine value and timestamps for each check, indicating a processing error.",
      "Patient is hypotensive (MAP 59 mmHg, SBP 82 mmHg). Hypotension markedly increases the risk of contrast‑induced nephropathy (CIN) and may limit the safety of standard hydration protocols.",
      "Stage 3a CKD (eGFR 59) is not severe, but the combination of prerenal azotemia (BUN/Cr = 20), anemia, and recent ICU stay raises the risk beyond what the protocol’s renal safety note (which only warns when eGFR < 30) captures.",
      "Protocol selection does not specify contrast type (low‑osmolar vs. iso‑osmolar) or a reduced contrast volume tailored to the patient’s renal function and hemodynamics.",
      "Hydration recommendation is generic (1 mL/kg/hr) and does not account for the patient’s low MAP; aggressive fluids could worsen hypotension.",
      "No plan for post‑contrast renal function monitoring (e.g., repeat creatinine at 24 h and 48 h) is described.",
      "Alternative imaging options are limited to a V/Q scan; bedside transthoracic echocardiography for right‑ventricular strain could also aid PE assessment without contrast."
    ],
    "recommendations": [
      "Obtain a repeat serum creatinine (and BUN) with an exact timestamp immediately before contrast administration to verify current renal function.",
      "Document the patient’s height and weight to calculate BMI and weight‑based contrast dose accurately.",
      "If MAP remains <65 mmHg, consider a brief fluid bolus (e.g., 250 mL isotonic saline) followed by a reduced maintenance rate (0.5 mL/kg/hr) and simultaneous hemodynamic support (e.g., low‑dose norepinephrine) to stabilize blood pressure before contrast exposure.",
      "Use low‑osmolar or iso‑osmolar iodinated contrast and limit volume to the minimum required for pulmonary arterial opacification (e.g., 80–100 mL, weight‑based, instead of 100–150 mL).",
      "Apply a contrast‑dose‑to‑eGFR ratio calculation; aim for <1.0 g I/mL/min for added safety in this borderline renal function patient.",
      "Schedule post‑contrast renal labs at 24 hours and 48 hours, with clinical monitoring for any rise in creatinine (>0.3 mg/dL or 25% increase).",
      "If hemodynamic instability cannot be corrected or if repeat creatinine rises, abort contrast‑based imaging and proceed with a V/Q scan or bedside echocardiography for PE evaluation.",
      "Update the renal decision support tool with correct BMI and lab timestamps; consider re‑running the tool after the new labs are obtained to obtain a more reliable risk assessment.",
      "Add a note in the imaging order to alert the technologist and radiologist to the patient’s hypotension and CKD, prompting low‑dose contrast protocol and close post‑scan monitoring."
    ],
    "confidence": 0.77
  }
}